Altimmune (ALT) Change in Intangibles (2016 - 2021)
Altimmune (ALT) reported Change in Intangibles of $5000.0 for Q4 2021, down 87.36% year-over-year from $39571.0 in Q4 2020, and down 88.89% quarter-over-quarter from $45000.0 in Q3 2021.
Altimmune (ALT) Change in Intangibles (2016 - 2021) Analysis & Trends
Altimmune (ALT) has 6 years of Change in Intangibles data on file, last reported at $5000.0 in Q4 2021.
- Change in Intangibles for Q4 2021 came in at $5000.0, down 87.36% year-over-year; the trailing twelve-month figure through Dec 2021 was $195000.0 (up 40.83% YoY), and the FY2021 annual result was $195000.0, up 40.83% from the prior year.
- Change in Intangibles fell to $5000.0 in Q4 2021 per ALT's latest filing, from $45000.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $83000.0 in Q2 2021 and troughed at $1082.0 in Q4 2018.
- A 5-year average of $22767.4 and a median of $14079.5 in 2017 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2020 and 2021: Change in Intangibles jumped 1565.45% in 2020, then sank 87.36% in 2021.
- A 5-year view of Change in Intangibles shows it stood at $6252.0 in 2017, then slumped by 82.69% to $1082.0 in 2018, then soared by 119.59% to $2376.0 in 2019, then jumped by 1565.45% to $39571.0 in 2020, then slumped by 87.36% to $5000.0 in 2021.
- Business Quant data shows ALT's Change in Intangibles at $5000.0 in Q4 2021, $45000.0 in Q3 2021, and $83000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Jun 30, 2021 | 83,000.00 |
| Jun 30, 2021 | 83,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 39,571.00 |
| Dec 31, 2020 | 39,571.00 |
| Sep 30, 2020 | 19,557.00 |
| Sep 30, 2020 | 19,557.00 |
| Jun 30, 2020 | 59,946.00 |
| Jun 30, 2020 | 59,946.00 |
| Mar 31, 2020 | 19,390.00 |
| Mar 31, 2020 | 19,390.00 |
| Dec 31, 2019 | 2,376.00 |
| Dec 31, 2019 | 2,376.00 |
| Sep 30, 2019 | 9,522.00 |
| Sep 30, 2019 | 9,522.00 |